Key drivers for each region include: for North America, policies supporting infection control, demographics with an aging population, and infrastructure with well-established healthcare systems; for Europe, adoption of molecular diagnostics, investments in research and development, and ecosystem maturity with a strong presence of key market players; for Asia Pacific, demographics with a large and growing population, infrastructure development, and policies supporting healthcare expansion; for Latin America, adoption of point-of-care diagnostics, investments in healthcare infrastructure, and ecosystem maturity with a growing presence of international market players; and for Middle East & Africa, policies supporting healthcare development, infrastructure investments, and demographics with a growing and young population.